Clancare Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 21-12-2024
- Paid Up Capital ₹ 0.10 M
as on 21-12-2024
- Company Age 5 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.80 M
as on 21-12-2024
- Revenue 46.75%
(FY 2022)
- Profit -2213.51%
(FY 2022)
- Ebitda -5.40%
(FY 2022)
- Net Worth -130.97%
(FY 2022)
- Total Assets 16.31%
(FY 2022)
About Clancare Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.80 M.
Harpreet Nimber, Gurdeep Singh, and Anuj Kumar serve as directors at the Company.
- CIN/LLPIN
U74999CH2019PTC042347
- Company No.
042347
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Jan 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Clancare Lifesciences Private Limited offer?
Clancare Lifesciences Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Gastrointestinal Drugs, Nutraceuticals & Dietary Supplements, Multivitamin Syrup & Drops, Pain Relief Drugs & Pharmaceuticals, Diclofenac, Common Disease Medicines, Pharmaceutical Syrup, Aceclofenac, Vitamin Tablets & Capsules.
Who are the key members and board of directors at Clancare Lifesciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Harpreet Nimber  | Director | 23-Jan-2019 | Current |
| Gurdeep Singh | Director | 23-Jan-2019 | Current |
| Anuj Kumar | Director | 22-Jun-2020 | Current |
Financial Performance of Clancare Lifesciences.
Clancare Lifesciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 46.75% increase. The company also saw a substantial fall in profitability, with a 2213.51% decrease in profit. The company's net worth observed a substantial decline by a decrease of 130.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Clancare Lifesciences?
In 2022, Clancare Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Reoster Lifesciences Private LimitedActive 2 years 6 months
Harpreet Nimber and Anuj Kumar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 04 Nov 2022 | ₹3.80 M | Open |
How Many Employees Work at Clancare Lifesciences?
Unlock and access historical data on people associated with Clancare Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Clancare Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Clancare Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
